Song, K. (2018). Increased Synthesis of MCL-1 Protein Underlies Initial Survival of EGFR-Mutant Lung Cancer to EGFR Inhibitors and Provides a Novel Drug Target. The American Association for Cancer Research (AACR).
Chicago Style (17th ed.) CitationSong, K.-A. Increased Synthesis of MCL-1 Protein Underlies Initial Survival of EGFR-Mutant Lung Cancer to EGFR Inhibitors and Provides a Novel Drug Target. The American Association for Cancer Research (AACR), 2018.
MLA (9th ed.) CitationSong, K.-A. Increased Synthesis of MCL-1 Protein Underlies Initial Survival of EGFR-Mutant Lung Cancer to EGFR Inhibitors and Provides a Novel Drug Target. The American Association for Cancer Research (AACR), 2018.
Warning: These citations may not always be 100% accurate.